| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10059222 | HBV | ENSG00000091513.16 | protein_coding | TF | No | No | 7018 | A0PJA6 P02787 Q06AH7 |
| TVIS10060582 | HBV | ENSG00000091513.16 | protein_coding | TF | No | No | 7018 | A0PJA6 P02787 Q06AH7 |
| TVIS44009820 | HTLV-1 | ENSG00000091513.16 | protein_coding | TF | No | No | 7018 | A0PJA6 P02787 Q06AH7 |
| TVIS44034265 | HTLV-1 | ENSG00000091513.16 | protein_coding | TF | No | No | 7018 | A0PJA6 P02787 Q06AH7 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | TF |
|---|---|
| DrugBank ID | DB00515 |
| Drug Name | Cisplatin |
| Target ID | BE0000510 |
| UniProt ID | P02787 |
| Regulation Type | |
| PubMed IDs | 16773208 |
| Citations | Khalaila I, Bergamo A, Bussy F, Sava G, Dyson PJ: The role of cisplatin and NAMI-A plasma-protein interactions in relation to combination therapy. Int J Oncol. 2006 Jul;29(1):261-8. |
| Groups | Approved |
| Direct Classification | Transition metal chlorides |
| SMILES | [H][N]([H])([H])[Pt](Cl)(Cl)[N]([H])([H])[H] |
| Pathways | |
| PharmGKB | PA449014 |
| ChEMBL | CHEMBL11359 |
